Exacerbations of asthma often occur during acute viral respiratory infections,'2 but no consensus has been reached as to whether they can initiate asthma in the first instance. One view is that acute viral respiratory infections damage the bronchial epithelium, and that this damage can lead to asthma. 3 The other is that a predisposition (genetic or otherwise) is required to allow this to happen, and only transient damage occurs in previously normal individuals. 4 There is a strong link between infantile bronchiolitis and the asthmatic symptoms in later childhood.5`7 In one uncontrolled prospective study of 48 children with bronchiolitis 92% were diagnosed as asthmatic at some time within the ensuing five years.8 In another study 73 children admitted to hospital with infantile bronchiolitis were followed for an average of 5 5 years; 42-5% reported wheezing within the final year compared with 151% of controls.9 The frequency of asthmatic symptoms appears to decline with time and may disappear between the ages of 8 and 13 years.'0 Other studies suggest that hyperresponsiveness to inhaled histamine may persist for 10 years or more after acute bronchiolitis," and might even predispose to pulmonary disease in adult life.'2-14 Some studies5 681 5 show no evidence that an atopic predisposition is required for bronchial hyperreactivity to develop, although others are equivocal9 or suggest that atopy strengthens the association.16 '9 These apparently conflicting views as to whether viral infections can initiate asthma are reconcilable, and fig 1 shows how both standpoints may be accommodated. According to this scheme, viruses cause epithelial damage in normal individuals which tends to resolve completely and rarely causes wheezing or chronic epithelial inflammation. In a genetically predisposed individual (or one already predisposed by previous or concurrent infection, bronchiectasis, or inhalation of irritants) the acute epithelial damage is more likely to be complicated by wheeze or by the vicious cycle of chronic inflammation, predisposing to further acute damage with subsequent virus infections. These chronic changes provide the setting for the lymphocytic20 and eosinophilic2' bronchitis which is seen in chronic asthma, and for the consequent bronchial hypersensitivity and airflow obstruction.
One intriguing question is whether the association between virus-mediated epithelial damage and asthma is one of chance, or the consequence of sophisticated survival strategies evolved by viruses. The number and diversity of common cold viruses suggests that they occupy a particularly desirable ecological niche. Over millions of years of co-evolution an equilibrium may have been reached whereby the injury which they cause is the least that is compatible with the optimal dissemination to other individuals, while allowing the maintenance of the social activities which are essential to viral spread. This contrasts with new viruses (such as HIV) which appear relatively maladapted, immunologically crude, and often lethal. If these generalisations are correct, it might be expected that old and well adapted viruses would have had the opportunity and motive to acquire subtle and specific abilities to modify host immune responses to their own advantage.
Recent work indicates that this may well be so, at least for respiratory syncytial virus (RSV). This pathogen causes most cases of bronchiolitis in children and regularly reinfects adults, causing colds. We have focused on isolating and testing specific immune responses to viral antigens from RSV, in particular on studies of T cells in the mouse (an animal which has contributed more to modern immunology than any other species). In 1988 we showed that CD8 + MHC class I restricted cytotoxic T lymphocytes were able to kill virus-infected cells and eliminate infection in vivo. However, a high level of cytotoxic T lymphocyte activity early during infection also causes severe lung damage, with changes on bronchial lavage which resemble those of shock lung (adult respiratory distress syndrome).22 This augmentation of disease is reminiscent of the problems seen in the 1960s when a killed RSV vaccine produced disease of increased severity in many of the children who subsequently became infected.
Recently 
Conclusions
Asthma and acute viral respiratory infections are both among the commonest of respiratory afflictions. There is a strong association between viral respiratory infections and both the onset and exacerbation of asthma, and the nature of this association is an important area for future research. Recent information suggests that this link may not be wholly accidental but may reflect specific interactions of viral proteins with the host immune system. Delayed effects of viral infection can arise in curious and novel ways; we must look for viral effects free of preconceived notions about the normal site or duration of infection. This may only be possible using the latest molecular techniques, particularly the polymerase chain reaction. Finally, the host immune system is not fixed at birth; previous and concurrent infections could produce long term effects which predispose to disease in later life.
